SEC Filings

Filing date	Description	Form	Filing Group	Issuer	View
View HTML 0000899243-19-016953.pdf 0000899243-19-016953.rtf	Jun 13, 2019	Statement of changes in beneficial ownership of securities	4	3,4,5	Eidos Therapeutics, Inc.
View HTML 0000899243-19-016956.pdf 0000899243-19-016956.rtf	Jun 13, 2019	Statement of changes in beneficial ownership of securities	4	3,4,5	Eidos Therapeutics, Inc.
View HTML 0000899243-19-016042.pdf 0000899243-19-016042.rtf	Jun 07, 2019	Statement of changes in beneficial ownership of securities	4	3,4,5	Eidos Therapeutics, Inc.
View HTML 0000899243-19-015848.pdf 0000899243-19-015848.rtf	Jun 06, 2019	Statement of changes in beneficial ownership of securities	4	3,4,5	Eidos Therapeutics, Inc.
View HTML 0000899243-19-015285.pdf 0000899243-19-015285.rtf	May 31, 2019	Statement of changes in beneficial ownership of securities	4	3,4,5	Eidos Therapeutics, Inc.
View HTML 0001193125-19-159860.pdf 0001193125-19-159860.rtf 0001193125-19-159860.xls	May 30, 2019	An amendment to a SC 13D filing	SC 13D/A	3,4,5	Eidos Therapeutics, Inc.
View HTML 0000899243-19-015088.pdf 0000899243-19-015088.rtf	May 29, 2019	Statement of changes in beneficial ownership of securities	4	3,4,5	Eidos Therapeutics, Inc.
View HTML 0000899243-19-015089.pdf 0000899243-19-015089.rtf	May 29, 2019	Statement of changes in beneficial ownership of securities	4	3,4,5	Eidos Therapeutics, Inc.
View HTML 0000899243-19-015091.pdf 0000899243-19-015091.rtf	May 29, 2019	Statement of changes in beneficial ownership of securities	4	3,4,5	Eidos Therapeutics, Inc.
View HTML 0000899243-19-015092.pdf 0000899243-19-015092.rtf	May 29, 2019	Statement of changes in beneficial ownership of securities	4	3,4,5	Eidos Therapeutics, Inc.